Related Experiment Video
Updated: Feb 11, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
Lenvatinib for the treatment of renal cell carcinoma
Giandomenico Roviello1, Silvia Paola Corona2, Giovanni Bozza1
1a Division of Medical Oncology, Department of Onco-Hematology , IRCCS-CROB, Referral Cancer Center of Basilicata , Rionero, Vulture , Italy.
Introduction:
Renal cell carcinoma (RCC) accounts for 2-3% of all solid tumors. Expression of the receptor for the vascular endothelial growth factor (VEGF) is one of the most common features of RCC.
Areas Covered:
Lenvatinib is a novel multi-kinase inhibitor that has been studied in several solid tumors. It has shown promising results in the treatment of RCC, especially when combined with everolimus, In this review, we summarize the available data of lenvatinib for the treatment of advanced/metastatic renal cell carcinoma.
Expert Opinion:
Lenvatinib in combination with everolimus has provided encouraging results in both clinical and laboratory investigations showing that blocking angiogenesis and the mTOR signalling pathway could be a remarkable approach for treating RCC. As an additive to this type of approach it would be interesting in future clinical settings testing also the combination of lenvatinib and everolimus with immune-therapy.
Insights
Lenvatinib combined with everolimus shows promise for advanced renal cell carcinoma (RCC) by targeting angiogenesis and mTOR signaling. Future research may explore adding immunotherapy to this combination for enhanced RCC treatment.
Area of Science:
- Oncology
- Pharmacology
Background:
- Renal cell carcinoma (RCC) represents 2-3% of all solid tumors.
- Vascular Endothelial Growth Factor (VEGF) receptor expression is a common feature in RCC.
Purpose of the Study:
- To review available data on lenvatinib for advanced/metastatic renal cell carcinoma.
- To summarize the efficacy of lenvatinib, particularly in combination with everolimus.
Main Methods:
- Review of clinical and laboratory data on lenvatinib in RCC treatment.
- Analysis of combination therapy including lenvatinib and everolimus.
Main Results:
- Lenvatinib, a multi-kinase inhibitor, shows promising results in RCC treatment.
- The combination of lenvatinib and everolimus demonstrates encouraging outcomes.
Conclusions:
- Blocking angiogenesis and mTOR signaling pathways is a viable strategy for RCC.
- Future studies should investigate combining lenvatinib, everolimus, and immunotherapy for advanced RCC.
More Related Videos
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Drug Elimination: Non-Renal Routes
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...